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SUMMARY: 
  In the absence of a national data on antimicrobial resistance in pediatric population in India, 
this work serves as a first large pooled data review highlighting the extremely high resistance 
in the commonly isolated blood-borne pathogens in Indian neonates and children against all 
routinely used antibiotics. 
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ABSTRACT 
Background 
 There is real shortage of national data on antimicrobial resistance rates in Indian neonates 
and children. A descriptive review was conducted to determine the patterns of antimicrobial 
resistance in isolates of bloodstream infection among hospitalised children in India 
Methods 
Published and grey literature on antibiotic resistance in children was searched using “Google 
Scholar”, “Scopus” and “Pubmed” databases between January 2000 and July 2015. Studies 
were included if they were original articles that reported a minimum of 10 pathogenic 
bacterial isolates from the bloodstream within a pediatric population in India, and excluded if 
they reported studies done during an outbreak or epidemic. 
Results 
A total of 1,179 studies were screened, and 82 papers were identified as eligible for inclusion. 
Most studies (78.7%) were reported from neonatal intensive care units. Among a total of 
50,545 reported blood cultures, 14,704(29.1%) were positive. Staphylococcus aureus, 
(median:14.7%;IQR7.4%-25.6%) and Klebsiella pneumoniae (median:26%;IQR16.7%-
35.4%) were the commonest reported gram-positive and gram-negative pathogens 
respectively. Around half of all Staphylococcus aureus isolates were reported as methicillin 
resistant Staphylococcus aureus (median:50%;IQR31.4%-65.1%). After age stratification, 
the median rate of resistance of common gram-negative pathogens to ampicillin and 
gentamicin/amikacin were extremely high. (Klebsiella pneumoniae/ampicillin 95.9% ; 
Klebsiella pneumoniae/gentamicin 75% ; Escherichia  coli/ampicillin 92.9% ; Escherichia 
coli/gentamicin 55.6%) .Similarly the median resistance of common gram-negative blood 
stream isolates to cephalosporins were also high (Klebsiella pneumoniae/cefotaxime 62.6% ; 
Escherichia coli/cefotaxime 47.5% ).  
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Conclusions 
High rates of resistance to WHO recommended first-line treatment options for neonates and 
children have been identified in blood stream infections across India. There is an urgent need 
to both enhance antibiotic stewardship and infection prevention and control measures and 
consider urgently how to repurpose older antibiotics back into routine care in India.  
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MANUSCRIPT 
 
Introduction 
There has been a relentless rise in antimicrobial resistance globally. Concerns about this 
serious threat have been raised since late 1990s as evident by the Global Strategy for 
Containment of Antimicrobial Resistance of the World Health Organisation (WHO) in 
2001[1]. 
 
The WHO in its recent global surveillance report states that this reality of 
antimicrobial resistance is “far from an apocalyptic fantasy”, is happening right now in every 
region of the world and has the potential to affect anyone, of any age, in any country[2]. 
Due to lack of a national robust surveillance system for Antimicrobial Resistance (AMR) in 
India, there is currently no centrally reported AMR national database.  Earlier initiatives to 
generate AMR data include those carried out by the India clinical epidemiological network 
(INCLEN) and Indian network for surveillance of antimicrobial resistance (INSAR)[3,4]. In 
2011, the Indian Council of Medical Research (ICMR) launched the national policy for 
containment of antimicrobial resistance which includes sentinel surveillance of AMR phase 
wise across the country[5]. This surveillance has not defined any age stratification. The 
Jaipur Declaration in 2011[6]
 
and Chennai declaration[7] in the subsequent year framed 
consensus roadmaps to tackle AMR. 
AMR patterns can significantly differ in adult and children[8]. It is estimated that India has 
the highest neonatal mortality due to neonatal sepsis caused by bacteria resistant to first-line 
antibiotics[9]. Nearly one-fifth of neonates with sepsis die in the hospital and the mortality 
rises to 50% for those with culture-proven sepsis[10].
 
In the absence of any recent national 
data of AMR rates in blood stream infections in the Indian neonatal or pediatric population, 
this study aimed to review the published and unpublished data on AMR during 2000-2015 
from India.  
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Methods: 
The published and grey literature on antibiotic resistance in children in English literature was 
searched using the databases “Google Scholar” “Scopus” and Pubmed using keywords 
“India” AND “children” OR “pediatrics” OR “neonates” OR “infants” AND “antimicrobial 
resistance” OR “antibiotic resistance” OR “antibiotic susceptibility” OR “antibiotic 
sensitivity” AND “blood culture” (see supplementary material 1). Grey literature sources 
such as pediatric conference proceedings and national reports were examined individually. 
The period between 1 January 2000 and 1
st
 July 2015 was chosen to access maximum 
information of published abstracts and full text articles.  A single reviewer assessed the study 
quality and performed data extraction. 
Inclusion criteria included original articles describing studies performed in well described 
health centres in India, published between January 2000 and July 2015 that described blood 
culture-derived bacterial isolates from children from birth to 18 years, with determination of 
antimicrobial susceptibility patterns. Excluded studies were those that described less than 10 
pathogenic isolates, or those that did not distinguish bloodstream and non-bloodstream 
sources, and those performed in adult populations. Studies performed during outbreaks or 
epidemics were also excluded. Bacterial isolates of interest reviewed here included gram-
positive bacteria (Staphylococcus aureus, coagulase-negative Staphylococcus , Enterococcus 
fecalis) and gram- negative bacteria (Klebsiella pneumoniae, Escherichia coli, Pseudomonas 
aeruginosa , Enterobacter species ,Citrobacter species, Acinetobacter baumannii , Proteus 
species and Salmonella typhi). 
 
Statistical Analysis  
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The proportions (%) and ranges of individual blood-borne pathogens in infants and children, 
resistant to various drugs mentioned in Table 1, 2 and 3 were calculated. As the total number 
of reported blood cultures varied markedly between studies, proportions and ranges for 
pathogens were weighted by total sample size of blood cultures and given as weighted 
median of proportions (%) and inter-quartile ranges (IQRs). Similarly, median and inter-
quartile ranges (IQRs) of resistance rates attributable to a pathogen to recommended 
antibiotics were reported [11]. 
Results  
Search Analysis 
Electronic search on 9
th
 July 2015 identified 298 articles in Pubmed, 4,980 articles in the 
database of “Google scholar” and 243 articles in Scopus. Of the 4,980 articles, Google 
scholar engine displays only the first 1,000. Individual search of abstracts from national 
conferences of Indian Academy of Pediatrics identified 8 abstracts. 72 articles were common 
in both search engines. So, in total, 1,179 abstracts were reviewed. Most of the articles were 
excluded because the studies were done in children living outside India or in the adult 
population (Figure 1). Among the remaining 484 articles, those that met the exclusion criteria 
were excluded.  
Thus, 82 papers (see supplementary material 2) were included for analysis. Among these 82 
papers, some papers had multiple data sets covering multiple years. Since the data set 
belonging to a particular year was considered as a separate study, the total number of studies 
obtained was 89. The positive blood culture rate was calculated using 78 of the 89 studies, as 
the total number of blood cultures analysed were not available in the remaining 11 studies. 
 Study characteristics 
Among the 89 eligible studies that had provided data about positive blood cultures, 78.7% 
data were from neonates, 14.6% from children older than 1 month, and 6.7% studies were 
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done in both neonate and pediatric ages. Studies were spread across India, with 36% reports 
from North India, 31.5% from South, 16.9% from Western India, 12.4% from the East and 
3.4% from Central India. Out of the 89 studies, 98.9% had been conducted at a tertiary level 
health care centre and only one study (i.e. 1.1%) had been reported from a secondary level 
health care centre. The great majority of studies (78.7%) had been reported from NICU and a 
small percentage (<5%) from PICU ward, IPD, or their combinations. One study had 
screened enteric cases using blood cultures from the outpatient department[12]. 
Blood Culture positivity 
Data were available from a total of 16,777 positive blood cultures from 89 studies, which 
were used to examine the drug resistance of the isolates. The number of total blood cultures 
reported was available only in 78 of the 89 studies, which summed to a total 50,545 blood 
cultures. The positive blood culture rate was calculated from the 78 studies that, varied from 
7.2% to 88.5% with a median of 35.4% (IQR= 21.2% - 46.6%). 
Pathogens identified 
Among 72 studies that reported gram-positive bacteria the median of percentage gram-
positive bacteria was 29.2% (IQR=15.8%-36.8%). Among gram-positive bacteria, 
Staphylococcus aureus was found to be the most common isolate (median 14.7%; IQR 7.4%-
25.6%) followed by coagulase negative Staphylococcus (CONS) (median 10.4%; IQR 4.2%-
15.9%) and Enterococcus faecalis (median 0.9%;IQR 0%-4.4%) (Table 1). It was not 
possible to distinguish true pathogens of CONS from contaminants in this review.  
Gram-negative bacteria were reported in 81 studies. The median percentage gram-negative 
bacteria identified among all reported positive cultures was 61.0% (IQR=34.6% -67.9%). 
Among gram-negative bacteria, Klebsiella pneumoniae was found to be the most common 
isolate (median 26%; IQR 16.7%-35.4%) followed by Escherichia coli (Median 9.3%; IQR 
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4.7%-14.5%), Acinetobacter  baumanii (median 5.9%; IQR 2.1%-10.8%) and Pseudomonas 
aeruginosa (median 4.8%; IQR 2.4%-9.4%)  
Resistance of Gram-positive bacteria: 
50% of the Staphylococcus aureus isolates were methicillin resistant Staphylococcus aureus 
(MRSA). High resistance was also noted for Staphylococcus aureus to erythromycin (53%), 
cefotaxime (57%) and cotrimoxazole (57.7%) (Table1). Lower resistance pattern was shown 
by CoNS except to cotrimoxazole (69.9%). However Enterococcus faecalis showed very 
high resistance to antibiotics including penicillins (88.5%), gentamicin (68.5%) and 
ciprofloxacin (50%). No resistance was found to vancomycin, linezolid and teicoplanin in all 
the gram-positive bacteria reported. 
Resistance of Gram-negative bacteria: 
Details of the gram-negative resistance rates are provided in Table 2. High levels of 
resistance was reported in Klebsiella pneumoniae to ampicillin (95.2%) and cephalosporins 
(over 60%). The rates of reported resistance to tigecycline were 8.2%, colistin, 3.8% and 
meropenem, 1%. Reported resistance in Enterobacter spp. was 100% to ceftriaxone and 
aztreonam.  Resistance to piperacillin-tazobactam was 16.7%, ciprofloxacin (39%) and 
meropenem (16.7%). There were very high resistance rates identified in Escherichia coli 
(Table 2) to ampicillin (92.3%), chloramphenicol (63.9%) and ciprofloxacin (40%) and 
relatively lower resistance to amikacin (22.4%) and piperacillin-tazobactam (16.7%). 
Resistance to meropenem of 9.0% and colistin of 8.8% was noted. As seen in Table 2, high 
resistance of Pseudomonas aeruginosa was noted to ceftazidime (58.7%) which is often used 
empirically for Pseudomonas aeruginosa infections. There was high resistance (16.7%) noted 
of Pseudomonas aeruginosa to meropenem. 
In case of resistance of Acinetobacter baumanii  and Citrobacter spp. (table 2), though the 
resistance to cephalosporins are high, there was relatively less resistance to ciprofloxacin and 
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beta-lactam antibiotics including piperacillin-tazobactam and cefoperazone-sulbactam. 
Acinetobacter baumanii  infections were reported to have 11.5% resistance to meropenem. 
Salmonella typhi (Table 3) displayed a median resistance of 50% to ampicillin, 35% to 
nalidixic acid and 17.9% to chloramphenicol. However 6.3% resistance to ceftriaxone and 
16% to second-line antibiotics like azithromycin were also noted. 
Age-based stratification for commonly used pathogen-drug combinations (Table 4) 
Using age as criterion, the data was then split by age into neonatal (less than 1 month) and 
pediatric populations (age greater than 1 month) for commonly used pathogen-drug 
combinations. 
a. Gram-positive resistance in neonates vs pediatric population 
The overall resistance was found to be greater in neonatal age than pediatric age. However, 
this difference was not statistically significant. There was no resistance noted of isolates of 
Staphylococcus aureus and CONS  to vancomycin, and linezolid, in both age groups. 
b. Gram-negative resistance in neonates vs pediatric population 
The median resistances of common gram negative pathogens to the WHO recommended 
combination of ampicillin and gentamicin for the empiric treatment of neonatal sepsis were 
extremely high (Klebsiella pneumoniae /ampicillin 95.9% ; Klebsiella pneumoniae 
/gentamicin 75%  ; Escherichia coli/ampicillin 92.9% ; Escherichia coli/gentamicin 55.6%) 
and median resistance to cephalosporins were also high (Klebsiella pneumoniae /cefotaxime 
62.6% ; Escherichia coli/cefotaxime 47.5% ). 
Discussion  
Main findings 
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This literature review provides a comprehensive analysis on the antimicrobial resistance 
pattern of bacterial blood stream infection (BSI) in the pediatric population of India over the 
past 15 years. This study found higher reports of bacteraemia caused by gram-negative 
bacteria (53.3%) compared to gram-positive bacteria (30.9%).  
The majority of the BSI identified in this study (78.7%) were reported from tertiary NICU’s. 
These NICUs reported very high rates of MRSA BSI ( 53.6%). WHO recommends ampicillin 
plus an aminoglycoside (gentamicin or amikacin) as empirical treatment for community 
acquired neonatal sepsis[13].
 
Very high levels of resistance of more than 90% to ampicillin 
was noted among the majority of the gram-negative isolates and the median resistance to  
amikacin ranged from 22.4% to 50%. Cephalosporins contribute to over 50% of prescribed 
antibiotics in paediatrics in India[14,15]. Cephalosporins are recommended as first line 
antibiotics in various community acquired infections like enteric fever, meningitis and severe 
pneumonia. The high rates of resistance to cephalosporins in gram-negative BSI isolates of 
both the neonatal and pediatric population is concerning (Klebsiella pneumoniae/cefotaxime 
62.6% in neonates and 70% in children; Escherichia coli/cefotaxime 47.5% in neonates and 
50% in children). In addition, this study noted an emerging resistance to carbapenems. 
Comparison to other studies 
Despite concern about the high resistance reported from India, it is surprising to note the lack 
of published data from India. In a study from a mixed population of adults and children 
across 15 centres in India, the prevalence of MRSA was 42 per cent in 2008 and 40 per cent 
in 2009. However 60% of the isolates were from skin and soft tissue infections, while the 
present study reported only on blood culture isolates. No isolate was found to be resistant to 
vancomycin and linezolid similar to the present study[4]. 
A high incidence of  MRSA BSI in neonates  was  also reported from a large  prospective 
multisite cohort study by the Delhi Neonatal Infection Study (DeNIS) collaboration (38% ) 
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[16]. Though the rate of gram-negative sepsis and the most common gram-negative 
pathogens isolated in this study were similar to ours, the proportion of Acinetobacter spp 
identified (22%) was much higher than ours (5.9%).  On comparing our data with a 
systematic review of gram-negative antimicrobial resistance in sepsis in resource limited 
countries, the figures from Asian studies show a similar resistance pattern for gram-negative 
isolates except for a lower resistance to cotrimoxazole and chloramphenicol[11].  
Since 1990s, Salmonella typhi had acquired resistance to the former first line drugs 
recommended by WHO, ampicillin, chloramphenicol and fluoroquinolones[17].
 
In the 
present study, one third of invasive Salmonella isolates (35%) in children had resistance to 
nalidixic acid similar to the resistance of 37.3% found in the systematic review of Asian 
studies[10]. Ceftriaxone and azithromycin are currently recommended as first line and second 
line therapy for multidrug resistant typhoid fever, (MDRTF). However the resistance rates 
reported here were significant with ceftriaxone (6.3%) and azithromycin (16%). A recent 
review on multi drug resistant typhoid fever in India had similarly noted isolated reports of 
ceftriaxone resistance[18]. 
Study limitations 
This study has several biases and limitations such as: 
Selection bias 
 Over 80% of studies were reported from tertiary Intensive Care Units where children have 
prolonged length of stay and underlying medical conditions.  Most of the studies in the data 
were laboratory based, with very limited clinical information, and it was not possible to 
determine if the infections were community or hospital acquired. Despite the exclusion of any 
study reporting an outbreak, it is probable that some studies had unrecognised outbreaks. 
Surveillance bias 
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The data was largely contributed by tertiary medical centres. It is noted from CDC’s 
surveillance on antimicrobial resistance [19, 20] that expansion of surveillance to include 
smaller community hospitals  (<200 beds) resulted in reduction in the pooled mean percent 
resistance for certain resistance phenotypes like MRSA.   
Reporting bias 
The heterogeneity in data showed the lack of any uniform protocol being followed for 
reporting key drug bug combination data in a standardised manner. There were no formal 
national guidelines on reporting antimicrobial resistance until February 2015 when the Indian 
Council of Medical Research announced the Standard Operating Procedure (SOP)[21].  
Next steps 
Although there are many limitations and biases, this study clearly highlights the concerning 
level of antimicrobial resistance in serious infections within the tertiary neonatal and pediatric 
setting in India. It is important to differentiate between hospital acquired and community 
acquired infections to develop appropriate empirical therapy choices. Guidelines on regional 
empirical treatment cannot be made on the basis of the present study as it is not representative 
of the resistance in the community [22]. Improved multi-centre, prospective studies using a 
standardised protocol such as the DeNIS study, are required, with data on underlying disease, 
treatment and clinical outcomes, which are essential to give a more accurate assessment of 
the true burden of disease, especially in relation to the clinical outcome.  
The factors contributing to antimicrobial resistance in India are complex and diverse and 
range from unregulated use of antibiotics in the community and hospital settings, poor 
infection control policies and the unavailability of culture facilities or point of care tests. The 
stewardship programmes recommended by the developed countries require time, personnel 
and resources which are currently completely lacking in the Indian health care system. It is 
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very important to develop simple, easy to implement antimicrobial stewardship programme 
adapted to resource poor settings.  
In 2016, the Government of India launched the national treatment guidelines for 
antimicrobial use in infectious diseases [23]. While this is a major step to ensure a uniform 
rational practice in the country, there is a need to formulate a similar guideline for neonates 
and children. In addition, participation of paediatricians should be encouraged in active 
surveillance for antibiotic resistance by bodies like ICMR, Indian Academy of Pediatrics and 
international networks. More importantly, the awareness about the magnitude of antibiotic 
resistance and the essence of rational antibiotic use needs to be highlighted more urgently  
among  practicing physicians and families.  Resistance rates to current antibiotics are now so 
high, that there is an urgent need to consider how to re-introduce older antibiotics back into 
routine clinical practice and determine how the very few new antibiotics under development 
can be introduced into high risk clinical care in a rational and affordable manner.  
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Figure Legend 
Figure 1: Flow Chart of selection of studies based on PRISMA 2009 flow chart 
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TABLES 
Table 1: Median and IQR of percentage resistance of gram-positive bacteria: Staphylococci 
aureus, CONS and Enterococcus faecalis 
  Staphylococcus aureus 
14.7%(7.4%-25.6%) 
[n=70] 
CONS 
10.4%(4.2%-15.9%) 
[n=68] 
Enterococcus faecalis 
0.9%(0%-4.4%) 
[n=44] 
Penicillin NS NS 88.5% (41.7%-100.0%)  
[n=9] 
Ampicillin NS NS 100.0% (77.5%-100.0%) 
[n=4] 
Erythromycin 53.0% (39.5%-65.9%) 
[n=31] 
43.3% (30.5%-67.1%) 
[n=26] 
53.2% (44.6%-61.9%)  
[n=8] 
Cloxacillin 50.0% (31.4%-65.1%) 
[n=33] 
42.5% (19.1%-66.7%) 
[n=24] 
NS 
Amikacin 25.8% (14.2%-48.7%) 
[n=40] 
28.6% (0.0%-41.0%) 
[n=35] 
NS 
Gentamicin 44.9% (24.9%-69.7%) 
[n=42] 
50.0% (29.2%-66.7%) 
[n=36] 
68.5% (41.7%-77.5%)  
[n=13] 
Cephelexin 34.3% (27.3%-66.6%) 
[n=11] 
27.3% (0.0%-51.5%) 
[n=10] 
NS 
Cefotaxime 57.1% (25.0%-66.0%) 
[n=23] 
35.4% (18.4%-64.1%) 
[n=22] 
NS 
Ceftriaxone 40.0% (21.4%-60.0%) 
[n=11] 
33.0% (9.0%-47.9%)  
[n=9] 
NS 
Cotrimoxazole 57.7% (30.0%-72.7%) 
[n=19] 
69.9% (60.6%-87.3%) 
[n=16] 
75.0% (12.5%-100.0%)  
[n=4] 
Ciprofloxacin 40.0% (25.0%-59.0%) 
[n=39] 
38.9% (16.7%-53.6%) 
[n=31] 
50.0% (0.0%-64.4%)  
[n=10] 
Amoxiclav 25.0% (16.0%-53.6%) 
[n=9] 
11.1% (0.0%-40.3%) 
[n=11] 
20.0% (0.0%-40.0%)  
[n=2] 
Clindamycin 29.3% (15.9%-40.2%) 
[n=14] 
27.5% (6.1%-37.1%) 
[n=14] 
NS 
Vancomycin 0.0% (0.0%-0.0%)  
[n=37] 
0.0% (0.0%-0.0%)  
[n=35] 
0.0% (0.0%-13.7%)  
[n=12] 
Linezolid 0.0% (0.0%-12.5%)  
[n=19] 
0.0% (0.0%-0.0%)  
[n=17] 
0.0% (0.0%-5.0%)  
[n=6] 
Teicoplanin 0.0% (0.0%-10.5%)  
[n=5] 
0.0% (0.0%-0.0%)  
[n=5] 
0.0% (0.0%-16.6%)  
[n=3] 
Doxycycline -NS -NS 40.0% (40.0%-40.0%)  
[n=1] 
    
* Data is presented in the form [median, (Inter quartile range:Q1-Q3), n=number of studies 
   NS : Not Studied. 
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Table 2: Median and IQR of percentage resistance of Gram-negative bacteria: Klebsiella pneumoniae, Enterobacter spp, Escherichia coli, 
Acinetobacter baumannii, Citrobacter spp and Pseudomonas aeruginosa 
  Klebsiella pneumoniae 
26%(16.7%-35.4%) [n=74] 
Enterobacter spp 
3.2%(0%-8.4%) [n =43] 
Escherichia coli 
9.3%(4.7%-14.5%) [n =72] 
Acinetobacter baumannii 
5.9%(2.1%-10.8%) [n =62] 
Citrobacter spp 
1.5%(0%-3%) [n =44] 
Pseudomonas aeruginosa 
4.8%(2.5%-9.4%) [n =65] 
Ampicillin 95.2% (74.0%-100.0%) [n=47] 100.0% (94.7%-100.0%) 
[n=19] 
92.3% (67.7%-100.0%) [n=32] 42.9% (7.0%-63.2%) [n=35] 99.0% (79.2%-100.0%) 
[n=10] 
NS 
Cephalexin 73.7% (49.5%-95.2%) [n=4] 100.0% (95.2%-100.0%) [n=3] 58.4% (58.3%-100.0%) [n=3] NS NS NS 
Cefazolin 76.5% (53.8%-100.0%) [n=3] NS  NS NS NS 
Cefotaxime 63.7% (40.9%-80.5%) [n=52] 70.4% (55.2%-90.3%) [n=22] 50.0% (40.0%-66.0%) [n=37] 60.0% (42.2%-90.6%) 
[n=29] 
60.0% (0.0%-69.1%) [n=13] NS 
Ceftriaxone 65.0% (28.7%-90.4%) [n=31] 100.0% (58.8%-100.0%) 
[n=11] 
50.0% (33.3%-66.7%) [n=19] 68.9% (49.6%-97.1%) 
[n=14] 
50.0% (0.0%-62.5%) [n=11] NS 
Ceftazidime 64.3% (44.4%-88.6%) [n=34] 67.0% (51.9%-97.6%) [n=13] NS 77.8% (50.0%-100.0%) 
[n=19] 
NS 58.7% (33.3%-73.7%) 
[n=26] 
Amikacin 41.0% (18.8%-50.5%) [n=65] 37.9% (20.6%-66.2%) [n=26] 22.4% (0.0%-40.0%) [n=43] NS 50.0% (18.6%-63.5%) 
[n=16] 
40.0% (25.0%-50.0%) 
[n=39] 
Gentamicin 75.7% (54.8%-86.8%) [n=64] 83.3% (65.8%-93.6%) [n=25] 55.6% (33.3%-83.3%) [n=43] 64.0% (45.0%-79.6%) 
[n=37] 
50.0% (33.4%-83.3%) 
[n=15] 
65.8% (50.0%-75.0%) 
[n=36] 
Ciprofloxacin 46.2% (28.4%-62.0%) [n=57] 39.0% (8.3%-62.1%) [n=23] 40.0% (22.9%-67.0%) [n=37] 52.8% (32.5%-63.2%) 
[n=34] 
33.4% (0.0%-64.8%) [n=16] 50.0% (32.5%-62.6%) 
[n=38] 
Chloramphenicol 59.2% (9.8%-77.3%) [n=14] 91.1% (51.7%-100.0%) [n=6] 63.9% (28.8%-84.9%) [n=8] 88.9% (65.3%-100.0%) 
[n=9] 
71.9% (37.5%-93.8%) [n=4] NS 
Amoxiclav 64.7% (33.0%-90.0%) [n=19] NS 74.5% (34.4%-87.8%) [n=12] NS 52.3% (12.5%-88.6%) [n=4] NS 
Piperacillin-
tazobactam 
42.0% (1.6%-61.4%) [n=22] 16.7% (0.0%-68.8%) [n=8] 16.7% (0.0%-40.0%) [n=11] 22.3% (0.0%-53.2%) [n=17] 0.0% (0.0%-37.5%) [n=4] 21.0% (1.2%-33.3%) [n=17] 
Cefoperazone-
sulbactam 
23.6% (9.5%-53.9%) [n=12] 23.8% (1.5%-85.4%) [n=4] NS 20.0% (9.4%-23.2%) [n=5] 1.0% (0.0%-1.9%) [n=2] NS 
Cotrimoxazole 62.5% (50.1%-80.7%) [n=25] NS 63.2% (50.0%-78.3%) [n=17] NS 33.4% (0.0%-50.0%) [n=7] NS 
Aztreonam 71.9% (19.0%-84.1%) [n=9] 100.0% (50.0%-100.0%) [n=3] 30.9% (2.9%-57.5%) [n=4] 22.2% (0.0%-86.1%) [n=4] 0.0% (0.0%-100.0%) [n=3] 45.0% (6.3%-83.3%) [n=5] 
Meropenem 1.0% (0.0%-17.4%) [n=17] 16.7% (0.0%-83.4%) [n=4] 9.0% (0.0%-27.0%) [n=11] 11.5% (0.0%-47.5%) [n=12] 0.0% (0.0%-0.0%) [n=3] 16.7% (0.0%-30.0%) [n=11] 
Colistin 3.8% (0.0%-21.4%) [n=3] NS 8.8% (0.0%-17.6%) [n=2] NS NS 0.0% (0.0%-0.0%) [n=2] 
Tigecycline 8.2% (1.0%-18.9%) [n=4] NS 0.0% (0.0%-0.0%) [n=1] NS NS NS 
* Data is presented in the form [median, (Inter quartile range:Q1-Q3), n=number of studies] 
   NS : Not Studied  
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Table 3: Median and IQR of percentage resistance of Salmonella Typhi 
  Salmonella typhi 
0%(0%-6.8%) 
[n=37] 
Ampicillin 50.0% (16.6%-87.1%) 
[n=9] 
Cefotaxime 0.0% (0.0%-13.6%) 
[n=7] 
Ceftriaxone 6.3% (0.0%-14.2%) 
[n=7] 
Ceftazidime 0.0% (0.0%-0.0%) 
[n=2] 
Ciprofloxacin 14.3% (0.0%-21.4%) 
[n=11] 
Chloramphenicol 17.9% (0.9%-62.1%) 
[n=8] 
Amoxiclav 0.0% (0.0%-14.3%) 
[n=3] 
Cotrimoxazole 12.2% (0.0%-45.1%) 
[n=8] 
Azithromycin 16.0% (0.0%-31.2%) 
[n=3] 
Nalidixic acid 35.5% (0.0%-81.3%) 
[n=5] 
* Data is presented in the form [median,(Inter quartile range:Q1-Q3), n=number of samples] 
   NS : Not Studied 
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Table 4: Age based pathogen resistance in common drug combinations 
Pathogen-
Antibiotic 
combination 
Neonate 
[Median(Q1-Q3) number 
of samples] 
Pediatric 
[Median(Q1-Q3) number 
of samples] 
P
$
 
Staphylococcus 
aureus - 
Cloxacillin 
53.6% (39.8%-66.2%) 
[#22] 
33.3% (29.3%-64.3%) 
[#11] 
0.08 
Staphylococcus 
aureus -
Clindamycin 
33.0% (20.0%-45.7%) 
[#11] 
27.7% (0.0%-30.0%) 
[#3] 
ns 
Staphylococcus 
aureus -
Vancomycin 
0.0% (0.0%-0.0%) 
[#30] 
0.0% (0.0%-0.0%) 
[#7] 
ns 
Staphylococcus 
Aureus -
Linezolid 
0.0% (0.0%-12.5%) 
[#14] 
0.0% (0.0%-13.2%) 
[#5] 
ns 
Klebsiella 
pneumoniae-
Ampicillin 
95.9% (76.2%-100.0%) 
[#42] 
93.9% (44.6%-100.0%) 
[#5] 
ns 
Klebsiella-
Gentamicin 
75.0% (54.8%-86.2%) 
[#56] 
83.6% (31.3%-98.5%) 
[#8] 
ns 
Klebsiella 
pneumoniae-
Cefotaxime 
62.6% (42.8%-80.2%) 
[#46] 
70.0% (14.3%-89.0%) 
[#7] 
ns 
Klebsiella 
pneumoniae–
Piperacillin-
tazobactam 
42.0% (5.1%-62.1%) 
[#20] 
25.0% (0.0%-50.0%) 
[#2] 
ns 
Klebsiella 
pneumoniae -
Imipenem 
0.0% (0.0%-8.0%) 
[#27] 
0.0% (0.0%-0.0%) 
[#5] 
ns 
Escherichia coli-
Ampicillin 
92.9% (66.7%-100.0%) 
 [#27] 
83.3% (62.0%-100.0%) 
 [#5] 
ns 
Escherichia coli-
Gentamicin 
55.6% (33.3%-83.3%)  
[#38] 
50.0% (0.0%-79.4%)  
[#5] 
ns 
Escherichia coli-
Amikacin 
22.3% (2.3%-40.0%) 
[#38] 
38.8% (0.0%-50.0%) 
[#5] 
ns 
Escherichia coli-
Cefotaxime 
47.5% (40.0%-66.3%) 
[#32] 
50.0% (45.0%-74.3%) 
[#5] 
ns 
Pseudomonas -
Amikacin 
39.4% (23.5%-50.0%)  
[#32] 
40.0% (25.0%-66.3%)  
[#7] ns 
Pseudomonas-
Ceftazidime 
50.0% (33.3%-73.3%) 
[#19] 
67.0% (33.3%-75.0%) 
[#7] 
ns 
Pseudomonas 
aeruginosa-
Ciprofloxacin 
43.0% (30.0%-60.0%) 
[#31] 
63.0% (40.0%-80.0%) 
[#7] 
ns 
Enterobacter spp- 100.0% (97.4%-100.0%) 97.1% (94.2%-0.0%) ns 
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Ampicillin [#17] [#2] 
Enterobacter spp-
Gentamicin 
88.0% (61.7%-97.4%) 
[#21] 
76.5% (67.6%-83.0%) 
[#4] 
ns 
Citrobacter spp-
Ampicillin 
95.3% (62.5%-100.0%) 
[#6] 
99.0% (87.0%-100.0%) 
[#4] 
ns 
Citrobacter spp-
Gentamicin 
52.8% (39.8%-80.3%) 
[#12] 
0.0% (0.0%-0.0%) 
[#3] 
ns 
Acinetobacter 
baumannii-
Gentamicin 
63.6% (45.0%-78.9%) 
[#33] 
77.1% (18.8%-94.8%) 
[#4] 
ns 
    
* Data is presented in the form [Median,(Inter quartile range:Q1-Q3), #number of samples] 
$ : significance levels using Mann-Whitney test ; ns – not significant 
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Figure 1: Flow Chart of selection of studies based on PRISMA 2009 flow chart 
 
 
 
Electronic records identified:  
• Google Scholar=4980 (only first 
1000 displayed on internet),  
• Pubmed=298 
• Scopus =243 
 
 
 
No of articles identified by hand 
search of conference abstracts= 8 
 
Records after duplicates 
removed=1179 
 
No. of records screened 1179 
No. of full text articles 
screened =484 
• No of papers included for 
analysis=82 
Considering multiple data sets 
/years  in the same publication 
as individual studies, total 
number of studies= 89 
No of records excluded by 
screening abstracts= 695 
No. of full text articles 
excluded= 402 
• Review articles: 143 
• Case reports: 102 
• Outbreaks: 17 
• Children not reported 
separately: 33 
• Multiple samples studied: 39 
• Studies which do not give 
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Author's Response to Decision Letter for (JPIDS-2016-098.R1) 
Extremely high rates of antimicrobial resistance in Indian 
neonates and children are now a major threat to public health. 
Grateful for your input.  
1. The abstract has been structured as suggested.  
2. The phrasing of the results changed as advised.  
3. Screening and statistical methods updated.  
4. Suggested minor edits carried out.  
5. Discussion curtailed by removing the repetitions and focusing on 
trends.  
6. Figure 2 deleted as advised  
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